Brief: Diaxonhit announces capital increase oversubscribed 1.6 times, step 1 for the acquisition of Eurobio
Feb 6 (Reuters) - Diaxonhit SA ALEHT.PA :
* Successful capital increase oversubscribed 1.6 times, successful step 1 for the
acquisition of Eurobio
* Full exercise of the extension clause bringing the total gross proceeds to 8.9 million
euros ($9.55 million)
* Total demand of 12.0 million euros (of which more than 1.3 million within the priority
period)
* 40 516 009 new shares to be issued
Source text for Eikon: ID:nGNE5TqDlP
Further company coverage: ALEHT.PA
($1 = 0.9318 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Eurobio Scientific SA
See all newsBrief: Eurobio Scientific EB Development Files Public Offer For Shares
Brief: Eurobio Scientific Says At End Of June 2024, Recorded Revenues Of 73.4 Mln Euros, Compared With 59.1 Mln Euros A Year Ago
Brief: Eurobio Scientific FY Core Business Revenues Up At EUR 130 Mln
Brief: Eurobio Scientific Cancels 694,300 Treasury Shares, Representing Around 6.34% Of Share Capital
Brief: Eurobio Scientific H1 Ebitda Up To EUR 13.4 Million